News & Blog: Article

Antibodies Incorporated Signs Long-Term Extension to UC Davis / NIH Neuromab Contract

Antibodies Incorporated is pleased to announce the signing of a multi-year extension to its existing arrangement as commercial partner of the UC Davis / NIH Neuromab Facility ("Neuromab").

Antibodies Incorporated has been the commercial partner for Neuromab since the Facility's initial funding in 2005. The long-term agreement ensures that the neuroscience research community will have continued access to the novel, highly-validated Neuromab antibody collection.

"We have proudly served as Neuromab's commercial partner since the Facility's inception, and we are proud to continue to offer neuroscience researchers these high quality products," said Dr. Richard Krogsrud, President of Antibodies Incorporated. "We offer a comprehensive collection of Neuromab products at https://www.antibodiesinc.com/pages/neuromab - the only location where researchers can access the entire Neuromab catalog. The multiyear agreement with Neuromab, combined with our company's own extensive product and service offerings, continues to position Antibodies Incorporated as the research partner for neuroscientists."

Antibodies Incorporated will be presenting at Booth #3329 at Neuroscience 2018 on November 4-7, 2018 at the San Diego Convention Center.

Find more information on the Neuromab product catalog and other Antibodies products and services, including exciting new offerings from our sister company, Aves Labs. Contact one of our product specialists at 1-800-824-8540.